Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis

Showing results (41-50 of 251) with videos related to

Pageof 26
Sort By:
Journal of Bioinformatics and Computational Biology|July 20, 2012
Beyond comparing means: the usefulness of analyzing interindividual variation in gene expression for identifying genes associated with cancer developmentIvan P Gorlov, Jinyoung Byun, Hongya Zhao, et al.
Plos One|November 21, 2012
Building a statistical model for predicting cancer genesIvan P Gorlov, Christopher J Logothetis, Shenying Fang, et al.
The Hastings Center Report|March 5, 2003
Revisiting ethical guidelines for research with terminal wean and brain-dead participantsRebecca D Pentz, Anne L Flamm, Renata Pasqualini, et al.
Cancer Immunity|June 27, 2007
Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancerChrysoula I Liakou, Sowmita Narayanan, Derek Ng Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2014
The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patientsYonggang He, Jian Gu, Sara Strom, et al.
Cancer Biology & Therapy|December 25, 2008
Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivityAbujiang Pataer, Stephen G Swisher, Jack A Roth, et al.
Plos One|August 5, 2009
GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an exampleIvan P Gorlov, Gary E Gallick, Olga Y Gorlova, et al.
Anti-Cancer Drugs|August 21, 2002
Enhanced suppression of prostate tumor growth by combining C-CAM1 gene therapy and angiogenesis inhibitor TNP-470Yeong-Shiau Pu, Kim-Anh Do, Weiping Luo, et al.
Frontiers in Oncology|March 31, 2018
Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate CancersRama Soundararajan, Ana M Aparicio, Christopher J Logothetis, et al.
Expert Opinion on Investigational Drugs|November 1, 2011
The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trialsAndreas Varkaris, Paul G Corn, Sanchaika Gaur, et al.
Pageof 26

Showing results (41-50 of 251) with videos related to

Sort By:
Pageof 26
Journal of Bioinformatics and Computational Biology|July 20, 2012
Beyond comparing means: the usefulness of analyzing interindividual variation in gene expression for identifying genes associated with cancer developmentIvan P Gorlov, Jinyoung Byun, Hongya Zhao, et al.
Plos One|November 21, 2012
Building a statistical model for predicting cancer genesIvan P Gorlov, Christopher J Logothetis, Shenying Fang, et al.
The Hastings Center Report|March 5, 2003
Revisiting ethical guidelines for research with terminal wean and brain-dead participantsRebecca D Pentz, Anne L Flamm, Renata Pasqualini, et al.
Cancer Immunity|June 27, 2007
Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancerChrysoula I Liakou, Sowmita Narayanan, Derek Ng Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2014
The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patientsYonggang He, Jian Gu, Sara Strom, et al.
Cancer Biology & Therapy|December 25, 2008
Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivityAbujiang Pataer, Stephen G Swisher, Jack A Roth, et al.
Plos One|August 5, 2009
GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an exampleIvan P Gorlov, Gary E Gallick, Olga Y Gorlova, et al.
Anti-Cancer Drugs|August 21, 2002
Enhanced suppression of prostate tumor growth by combining C-CAM1 gene therapy and angiogenesis inhibitor TNP-470Yeong-Shiau Pu, Kim-Anh Do, Weiping Luo, et al.
Frontiers in Oncology|March 31, 2018
Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate CancersRama Soundararajan, Ana M Aparicio, Christopher J Logothetis, et al.
Expert Opinion on Investigational Drugs|November 1, 2011
The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trialsAndreas Varkaris, Paul G Corn, Sanchaika Gaur, et al.
Pageof 26